GSK AND ASTRAZENECA CHIEFS TO CHAIR BREXIT WORKING GROUP

摘要

The chief executive officers of the UK's leading pharmaceutical companies will be advising the government on the main priorities for the life sciences sector in the event of the UK leaving the EU. Andrew Witty from GSK and Pascal Soriot from AstraZeneoa will be co-chairs of the ministerial working group — the EU steering group — which met for the first time on 6 July 2016.